Jupiter Neurosciences, Inc. Common Stock (NASDAQ:JUNS) — Market Cap & Net Worth
Market Cap & Net Worth: Jupiter Neurosciences, Inc. Common Stock (JUNS)
Jupiter Neurosciences, Inc. Common Stock (NASDAQ:JUNS) has a market capitalization of $3.86 Million ($3.86 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29155 globally and #5958 in its home market, demonstrating a -4.87% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jupiter Neurosciences, Inc. Common Stock's stock price $2.93 by its total outstanding shares 1318521 (1.32 Million). Also see total assets of Jupiter Neurosciences, Inc. Common Stock for a full breakdown of the balance sheet.
Jupiter Neurosciences, Inc. Common Stock Market Cap History: 2024 to 2026
Jupiter Neurosciences, Inc. Common Stock's market capitalization history from 2024 to 2026. Data shows change from $14.11 Million to $3.97 Million (-42.30% CAGR). Also see JUNS cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Jupiter Neurosciences, Inc. Common Stock is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.00% | #845 of 976 |
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.00% | #2709 of 3165 |
Weight: Jupiter Neurosciences, Inc. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Jupiter Neurosciences, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jupiter Neurosciences, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Jupiter Neurosciences, Inc. Common Stock for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
61.70x
Jupiter Neurosciences, Inc. Common Stock's market cap is 61.70 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $1.34 Million | $21.80K | -$8.64 Million | 61.70x | N/A |
Competitor Companies of JUNS by Market Capitalization
Companies near Jupiter Neurosciences, Inc. Common Stock in the global market cap rankings as of September 18, 2026. Review Jupiter Neurosciences, Inc. Common Stock tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Jupiter Neurosciences, Inc. Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #187 globally with a market cap of $130.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.34 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.87 Billion USD ( AU$84.62 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #505 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #187 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.09 Billion | $513.26 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.34 Billion | $774.61 |
| #457 | CSL Ltd | AU:CSL | $59.87 Billion | AU$174.41 |
| #505 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $145.62 |
Jupiter Neurosciences, Inc. Common Stock Historical Marketcap From 2024 to 2026
Between 2024 and today, Jupiter Neurosciences, Inc. Common Stock's market cap moved from $14.11 Million to $ 3.97 Million, with a yearly change of -42.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.97 Million | +195.10% |
| 2025 | $1.34 Million | -90.47% |
| 2024 | $14.11 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Jupiter Neurosciences, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.86 Million USD |
| MoneyControl | $3.86 Million USD |
| MarketWatch | $3.86 Million USD |
| marketcap.company | $3.86 Million USD |
| Reuters | $3.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jupiter Neurosciences, Inc. Common Stock
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements. The company researches and develops JNS115, which is in Phase IIa clinic… Read more